These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
78 related articles for article (PubMed ID: 6965763)
21. Platelet inhibitors in coronary-artery bypass operations. Gohlke H; Gohlke-Bärwolf C N Engl J Med; 1982 Dec; 307(23):1453-4. PubMed ID: 6752721 [No Abstract] [Full Text] [Related]
22. [Prevention of early graft occlusion after coronary bypass grafting by post-operative reduction of plasma fibrinogen by H.E.L.P. apheresis. First evaluation of 12 patients treated during our study (44 bypasses)]. Blessing F; Jaeger BR; Oberhoffer M; Reichart B; Seidel D Z Kardiol; 2003; 92(Suppl 3):III42-7. PubMed ID: 14663601 [TBL] [Abstract][Full Text] [Related]
24. [Problems of the operated patient and suggestions for their treatment]. De Vita C G Ital Cardiol; 1982; 12(3):227-30. PubMed ID: 6983468 [No Abstract] [Full Text] [Related]
25. Management of surgical patients receiving anticoagulation and antiplatelet agents. Thachil J; Gatt A; Martlew V Br J Surg; 2008 Dec; 95(12):1437-48. PubMed ID: 18991253 [TBL] [Abstract][Full Text] [Related]
26. Perioperative use of tirofiban hydrochloride (Aggrastat) does not increase surgical bleeding after emergency or urgent coronary artery bypass grafting. Bizzarri F; Scolletta S; Tucci E; Lucidi M; Davoli G; Toscano T; Neri E; Muzzi L; Frati G J Thorac Cardiovasc Surg; 2001 Dec; 122(6):1181-5. PubMed ID: 11726894 [TBL] [Abstract][Full Text] [Related]